Dopamine Depletion
Showing 1 - 25 of 1,301
Cerebral Contributions to Symptom Progression in PD
Active, not recruiting
- Parkinson Disease
-
Nijmegen, Gelderland, NetherlandsDonders institute for brain, cognition and behaviour
Dec 8, 2021
Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)
Suspended
- Disorder of Consciousness
- Traumatic Brain Injury
- Amantadine + L-DOPA
- NMDA blocker
-
New York, New YorkWeill Cornell Medicine
Sep 27, 2022
Attentional Performance in Parkinson Disease
Withdrawn
- Parkinson's Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 8, 2021
Search for New Methods to Detect Acute Renal Failure
Recruiting
- Kidney Disease
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Parkinson's Disease Trial in Nijmegen (MBCT)
Not yet recruiting
- Parkinson's Disease
- MBCT
-
Nijmegen, NetherlandsDonders Centre for Cognitive Neuroimaging
Mar 19, 2023
Pathophysiology of Gilles de la Tourette Syndrome. Part 1:
Not yet recruiting
- Gilles de la Tourette Syndrome
- Tourette Syndrome
- PET/MR scanner
-
Leipzig, GermanyMax Planck Institute for Human Cognitive and Brain Sciences
Feb 11, 2022
Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T
Recruiting
- Gilles de la Tourette Syndrome
- Tourette Syndrome
- MRI scanner (7 Tesla)
-
Leipzig, GermanyMax Planck Institute for Human Cognitive and Brain Sciences
Feb 10, 2022
Cocaine Dependence Trial in New Haven (Methylphenidate, Alpha Methyl Para Tyrosine (AMPT), [11C]PHNO)
Terminated
- Cocaine Dependence
- Methylphenidate
- +3 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Feb 24, 2021
Bulimia Nervosa, Eating Disorders, Dopamine Trial in Bern 60 (AMPT/ Demser, Diphenhydramine, Placebo)
Suspended
- Bulimia Nervosa
- +4 more
- AMPT/ Demser
- +2 more
-
Bern 60, SwitzerlandUniversity Hospital of Psychiatry, University of Bern
Jan 23, 2019
Glucose Tolerance Trial in New York (Tyrosine (TYR) Supplementation)
Completed
- Glucose Tolerance
- Tyrosine (TYR) Supplementation
-
New York, New YorkColumbia University Irving Medical Center
Apr 30, 2021
Schizophrenia Trial in Shanghai (sodium valproate with Clozapine, modified electroconvulsive therapy(MECT) with Clozapine,
Completed
- Schizophrenia
- sodium valproate with Clozapine
- +3 more
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 1, 2022
Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))
Not yet recruiting
- Leukemia
- +12 more
- Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
- (no location specified)
Mar 20, 2023
Acute Kidney Injury in Diabetic Ketoacidosis at Sohag University
Not yet recruiting
- Diabetic Ketoacidosis
- Acute Kidney Injury
- (no location specified)
May 18, 2023
The Meaning of Dopaminergic Pathway in Sleep Breathing
Enrolling by invitation
- Sleep Apnea
- Sleep-Disordered Breathing
- Polysomnography
- +2 more
-
Wroclaw, PolandWroclaw Medical Uniwesity
May 25, 2023
Energy Metabolism Trial in Madrid (Incremental exercise test, Incremental exercise test under hyperthermia, Incremental exercise
Recruiting
- Energy Metabolism
- Incremental exercise test
- +2 more
-
Madrid, SpainLaboratorio de Fisiología del Esfuerzo. Facultad de Ciencias de
Jan 26, 2023
Functional Relevance of Dopamine Receptors in Healthy Controls
Recruiting
- Schizoaffective Disorder
- Schizophrenia
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
Effect of Sulpiride on Working Memory Gating and Associated BOLD Signal in the Striatum, Effect of Sulpiride on the Influence of
Completed
- Effect of Sulpiride on Working Memory Gating and Associated BOLD Signal in the Striatum
- +2 more
- Sulpiride 400 MG
- Placebo
-
Nijmegen, Gelderland, NetherlandsDonders Centre for Cognition, Radboud University
May 22, 2023
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
Healthy Trial in Zürich (Psilocybin, 3,4 Methylenedioxymethamphetamine, Methylphenidate)
Recruiting
- Healthy
- Psilocybin
- +2 more
-
Zürich, SwitzerlandPsychiatrische Universitätsklinik Zürich
Oct 3, 2023
Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)
Not yet recruiting
- Hematologic Malignancy
- +21 more
- Fludarabine
- +4 more
- (no location specified)
Feb 9, 2023
Depressive Disorder, Major Trial (L-dopa/Carbidopa, Placebo)
Not yet recruiting
- Depressive Disorder, Major
- L-dopa/Carbidopa
- Placebo
- (no location specified)
Jun 11, 2023
Steroid-Dependent Nephrotic Syndrome, Steroid-Sensitive Nephrotic Syndrome Trial in Paris (single infusion of Rituximab, single
Not yet recruiting
- Steroid-Dependent Nephrotic Syndrome
- Steroid-Sensitive Nephrotic Syndrome
- single infusion of Rituximab
- single infusion of Obinutuzumab
-
Paris, FranceRobert Debre Hospital
Mar 14, 2023
Health Trial in Edmonton (Dopamine, Metoclopramide, Placebos)
Recruiting
- Health
- Dopamine
- +5 more
-
Edmonton, Alberta, CanadaClinical Physiology Research Laboratory
Apr 6, 2022